Buchumschlag

Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis

A defective mucociliary clearance facilitates colonization with bacteria and fungal spores in cystic fibrosis patients. Yeasts and molds are cultured from the cystic fibrosis respiratory tract and often their clinical relevance is unknown. Candida spp. are the most commonly isolated yeasts, whereas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Müller, Frank-Michael (VerfasserIn) , Seidler, Marc (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2010
In: Expert review of anti-infective therapy
Year: 2010, Jahrgang: 8, Heft: 8, Pages: 957-964
ISSN:1744-8336
DOI:10.1586/eri.10.72
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1586/eri.10.72
Volltext
Verfasserangaben:Frank-Michael C Müller & Marc Seidler

MARC

LEADER 00000caa a2200000 c 4500
001 1844964485
003 DE-627
005 20230710134842.0
007 cr uuu---uuuuu
008 230510s2010 xx |||||o 00| ||eng c
024 7 |a 10.1586/eri.10.72  |2 doi 
035 |a (DE-627)1844964485 
035 |a (DE-599)KXP1844964485 
035 |a (OCoLC)1389805748 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Müller, Frank-Michael  |e VerfasserIn  |0 (DE-588)1131201906  |0 (DE-627)885586905  |0 (DE-576)487895827  |4 aut 
245 1 0 |a Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis  |c Frank-Michael C Müller & Marc Seidler 
264 1 |c 2010 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Erstmals am 10 Jan 2014 online veröffentlicht 
500 |a Gesehen am 10.05.2023 
520 |a A defective mucociliary clearance facilitates colonization with bacteria and fungal spores in cystic fibrosis patients. Yeasts and molds are cultured from the cystic fibrosis respiratory tract and often their clinical relevance is unknown. Candida spp. are the most commonly isolated yeasts, whereas Aspergillus spp., Scedosporium apiospermum, as well as Exophiala dermatitidis in some countries, are the most frequent molds recovered from respiratory specimens. Molecular biotyping studies have revealed that some fungal genotypes are capable of chronically colonizing the airways. Persistent Aspergillus fumigatus infection is associated with an increased risk of pulmonary exacerbations requiring hospitalization. The prevalence of non-Aspergillus molds may be underestimated due to overgrowth of Pseudomonas and Aspergillus spp. on routine media. Allergic bronchopulmonary aspergillosis is usually treated by oral steroids and an antifungal azole drug. Interactions with the co-medication have to be considered. A small number of antifungal pharmacokinetic studies indicate a high inter-subject variability for itraconazole, voriconazole and posaconazole, and therefore therapeutic drug monitoring is recommended. 
650 4 |a antifungal drug resistance 
650 4 |a antifungal therapy 
650 4 |a Aspergillus 
650 4 |a Candida 
650 4 |a chronic persistence 
650 4 |a drug monitoring 
650 4 |a filamentous fungi 
650 4 |a Pneumocystis 
650 4 |a Scedosporium 
650 4 |a yeast 
700 1 |a Seidler, Marc  |d 1976-  |e VerfasserIn  |0 (DE-588)141083859  |0 (DE-627)624917126  |0 (DE-576)322091993  |4 aut 
773 0 8 |i Enthalten in  |t Expert review of anti-infective therapy  |d Abingdon, Oxon : Taylor & Francis, 2003  |g 8(2010), 8, Seite 957-964  |h Online-Ressource  |w (DE-627)47897499X  |w (DE-600)2176167-X  |w (DE-576)398100179  |x 1744-8336  |7 nnas  |a Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis 
773 1 8 |g volume:8  |g year:2010  |g number:8  |g pages:957-964  |g extent:8  |a Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis 
856 4 0 |u https://doi.org/10.1586/eri.10.72  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230510 
993 |a Article 
994 |a 2010 
998 |g 141083859  |a Seidler, Marc  |m 141083859:Seidler, Marc  |d 50000  |e 50000PS141083859  |k 0/50000/  |p 2  |y j 
998 |g 1131201906  |a Müller, Frank-Michael  |m 1131201906:Müller, Frank-Michael  |d 50000  |e 50000PM1131201906  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1844964485  |e 4320308522 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","display":"Müller, Frank-Michael","roleDisplay":"VerfasserIn","given":"Frank-Michael","family":"Müller"},{"family":"Seidler","given":"Marc","roleDisplay":"VerfasserIn","display":"Seidler, Marc","role":"aut"}],"title":[{"title_sort":"Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis","title":"Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Erstmals am 10 Jan 2014 online veröffentlicht","Gesehen am 10.05.2023"],"language":["eng"],"recId":"1844964485","name":{"displayForm":["Frank-Michael C Müller & Marc Seidler"]},"origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"2010"}],"id":{"doi":["10.1586/eri.10.72"],"eki":["1844964485"]},"physDesc":[{"extent":"8 S."}],"relHost":[{"pubHistory":["1.2003 -"],"part":{"issue":"8","pages":"957-964","year":"2010","extent":"8","text":"8(2010), 8, Seite 957-964","volume":"8"},"note":["Gesehen am 01.09.15"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosisExpert review of anti-infective therapy","language":["eng"],"recId":"47897499X","title":[{"title":"Expert review of anti-infective therapy","title_sort":"Expert review of anti-infective therapy"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Abingdon, Oxon ; London","publisher":"Taylor & Francis ; Informa UK","dateIssuedKey":"2003","dateIssuedDisp":"2003-"}],"id":{"issn":["1744-8336"],"eki":["47897499X"],"zdb":["2176167-X"]}}]} 
SRT |a MUELLERFRACHARACTERI2010 

Ähnliche Einträge